Autologous Noncryopreserved Hematopoietic Stem Cell Transplant With CEAM as a Modified Conditioning Regimen in Patients With Hodgkin Lymphoma: A Single-center Experience With a New Protocol

Abstract

These data demonstrate the safety and feasibility of BEAM-like regimen as a new and modified regimen; longer follow-up is required to evaluate fully efficacy and long-term safety of our method.